Integral Ad Science (IAS) – Analysts’ Weekly Ratings Changes
Several brokerages have updated their recommendations and price targets on shares of Integral Ad Science (NASDAQ: IAS) in the last few weeks: 11/14/2024 – Integral Ad Science had its “hold” rating reaffirmed by analysts at Benchmark Co.. 11/13/2024 – Integral Ad Science had its price target lowered by analysts at Piper Sandler from $18.00 to […]
More Stories
iShares IV Public Limited Company – iShares Edge MSCI World Momentum Factor UCITS ETF (OTCMKTS:IEMMF) Sees Large Growth in Short Interest
iShares IV Public Limited Company – iShares Edge MSCI World Momentum Factor UCITS ETF (OTCMKTS:IEMMF – Get Free Report) was...
Julius Bär Gruppe AG (OTCMKTS:JBAXY) Short Interest Update
Julius Bär Gruppe AG (OTCMKTS:JBAXY – Get Free Report) was the target of a large drop in short interest during...
Short Interest in T Stamp Inc. (NASDAQ:IDAI) Rises By 239.2%
T Stamp Inc. (NASDAQ:IDAI – Get Free Report) was the target of a significant increase in short interest during the...
Wells Fargo Advantage Funds – Allspring Global Dividend Opportunity Fund (NYSE:EOD) Sees Large Increase in Short Interest
Wells Fargo Advantage Funds – Allspring Global Dividend Opportunity Fund (NYSE:EOD – Get Free Report) saw a significant growth in...
BNY Mellon Strategic Municipals, Inc. (NYSE:LEO) Short Interest Update
BNY Mellon Strategic Municipals, Inc. (NYSE:LEO – Get Free Report) saw a significant drop in short interest in the month...
Avenue Therapeutics Receives Delist Letter from Nasdaq, Plans Hearing with Independent Panel
Avenue Therapeutics, Inc. (NASDAQ: ATXI), a pharmaceutical company based in Bay Harbor Islands, Florida, recently disclosed in a Form 8-K...